Head & Neck/Thyroid Cancers
Conference Coverage
New remote monitoring system lessens symptoms in head and neck cancer
The CYCORE system, which harnesses wireless sensor and mobile technology to remotely monitor vitals and symptoms, reduces symptom severity in...
News
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
Of 23 patients, 57% experienced a partial response and 4% experienced a full response.
Case Reports
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
Conference Coverage
Probe linked to smartphone found effective in diagnosing oral cancer
DALLAS – The device provides high-resolution polarized white light images in combination with autofluorescence imaging capability.
Conference Coverage
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
CHICAGO – Serum thyroglobulin is not the only sheriff in town for thyroid cancer follow-up.
Case Reports
Recurrent head and neck cancer presenting as a large retroperitoneal mass
Conference Coverage
Pembrolizumab plus SBRT shows promise for advanced solid tumors
Pembrolizumab immunotherapy with multi-site SBRT appears to be a safe and effective treatment in patients with advanced solid tumors.
Conference Coverage
New and improved classifiers may sharpen thyroid nodule diagnosis
VICTORIA, B.C. – The tests could improve preoperative assessment, even in histologic subsets that pose diagnostic challenges.
From the Journals
ASCO larynx-preservation guidelines reflect important practice changes
Larynx-preserving techniques do not compromise survival in patients with early-stage laryngeal cancers.
Case Reports
Management of tonsillar carcinoma with advanced radiation therapy and chemotherapy techniques
Conference Coverage
Cancer patients with TKI-induced hypothyroidism had better survival rates
When it comes to the adverse effects of tyrosine kinase inhibitors, hypothyroidism appears to have a bright side.